Assort Health Secures $26 Million in Funding to Expand Specialty-Specific Generative AI Platform for Managing Patient Phone Calls [Yahoo! Finance]
Astrana Health Inc. (ASTH)
Company Research
Source: Yahoo! Finance
SAN FRANCISCO, April 16, 2025 BUSINESS WIRE Assort Health , the most advanced specialty-specific AI platform for managing patient phone calls, today announced a new round of institutional financing co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capital. This brings Assort Health's total capital raised to $26 million. These investors join Assort Health's existing backers, Four Acres, Tau Ventures, and a number of notable angel investors, including senior executives and founders from Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto. The new capital will accelerate the company's mission to improve access to care by eliminating the lengthy hold times and scheduling inefficiencies that plague healthcare organizations. "In a recent Assort Health study, we uncovered that patients wait up to 35 minutes to schedule an appointment. From there, 20 million patients are booked with the wrong
Show less
Read more
Impact Snapshot
Event Time:
ASTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASTH alerts
High impacting Astrana Health Inc. news events
Weekly update
A roundup of the hottest topics
ASTH
News
- Astrana Health (NASDAQ:ASTH) was upgraded by analysts at Needham & Company LLC to a "moderate buy" rating.MarketBeat
- Astrana Health (NASDAQ:ASTH) is now covered by analysts at Needham & Company LLC. They set a "buy" rating on the stock.MarketBeat
- Astrana Health (NASDAQ:ASTH) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..MarketBeat
- Astrana Health (NASDAQ:ASTH) was given a new $37.00 price target on by analysts at Jefferies Financial Group Inc..MarketBeat
- Astrana Health (NASDAQ:ASTH) was given a new $26.00 price target on by analysts at Barclays PLC.MarketBeat